Triple-negative breast cancer (TNBC) is a breast cancer subtype defined by the lack of expression for estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (Kittaneh et al., 2013). This evidence concerns the gene ESR1 and breast carcinoma.